Charles E. Daniels, Ph.D.
The top pharmacist at the National Institutes of Health (NIH), Charles E. Daniels, Ph.D., comes to the University of California, San Diego (UCSD) October 1, 2004 in the newly created position of Pharmacist in Chief for UCSD Healthcare. In addition, he will serve as Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy in the UCSD School of Pharmacy and Pharmaceutical Sciences.
Currently Pharmacy Chief at the NIH Clinical Center, Daniels has extensive administrative experience in addition to his accomplishments in research and academia.
“Dr. Daniels is a leader in pharmacy,” said Edward W. Holmes, M.D., Vice Chancellor for Health Sciences and Dean, UCSD School of Medicine. “He’s the accomplished administrator of a national clinical and research pharmacy, an academic innovator who will develop our pharmacy clinical training programs, and a pharmacist with private sector experience which will help us build relationships with local biotech and pharmaceutical industries.”
Pharmacist in Chief is a new position which, combined with Daniels’ role as Associate Dean for Clinical Affairs, includes diverse and multifaceted duties such as the development of training sites for students, the oversight of clinical pharmacy activities within UCSD and its affiliated hospitals and clinics, and the coordination of pharmacy-related research and clinical trials.
“We are very excited that Dr. Daniels will join us,” said Palmer W. Taylor, Ph.D., Associate Vice Chancellor for Health Sciences and Dean, UCSD School of Pharmacy and Pharmaceutical Sciences. Commenting on Daniels’ extensive experience in clinical pharmacy academic and residency training, Taylor said “he brings a strong academic background from the University of Minnesota, as well as experience as director of pharmacy at one of the world-renowned clinical research and training settings, the Clinical Center at the National Institutions of Health.”
Daniels will direct pharmacy operations at UCSD Healthcare’s outpatient clinics and two hospitals in Hillcrest and La Jolla. As part of his coordination of clinical training for pharmacy students, Daniels plans to develop a network of pharmacy practitioners in the San Diego region who are committed to quality pharmacy practice and are ready to participate in the UCSD training programs.
Richard J. Liekweg, Chief Executive Officer for UCSD Medical Center, noted that “Dr. Daniels’ experience as chief of the premier research and clinical pharmacy program at the NIH, combined with years of directing the Department of Pharmacy operations at the University of Minnesota Hospital and Clinics, makes him uniquely qualified to serve as our Pharmacist in Chief and Associate Dean. In his role as the Medical Center’s Pharmacist in Chief, he will fully integrate our diverse clinical pharmacy practice with the new School of Pharmacy and Pharmaceutical Sciences. With his leadership, I am convinced that our academic practice will be a sought after destination for pharmacists, pharmacy students, and the pharmaceutical industry.”
Daniels said his position at UCSD is “a once in a lifetime opportunity to integrate the strong pharmacy services at UCSD Healthcare with high quality clinical training for students in the School of Pharmacy and Pharmaceutical Sciences. The leadership team has created a tremendous environment for a successful pharmacy program. I look forward to helping further develop this program in an outstanding research environment.”
As the nation’s newest pharmacy school, which admitted its first students in the fall of 2002, the UCSD School of Pharmacy and Pharmaceutical Sciences provides an unprecedented opportunity to use emerging technologies – the genetic revolution, recombinant DNA techniques and bioinformatics – in both education and research. Taking advantage of these latest disciplines, the school will train practicing pharmacists to work in clinical settings, as well as pharmaceutical scientists who will contribute to drug discovery and development.
“I tell students that the pharmacy role contains a unique mix of pure science, patient care and product responsibility,” Daniels said. “Because of that, I think the future is really bright for pharmacists.”
For the past nine years at the NIH, Daniels has been chief of the Pharmacy Department, where he provided leadership and direction to a large organization involved in clinical care and drug distribution, as well as research support and the development of an independent pharmacy-based research program.
“My NIH experience has given me an inside look at an organization with a focus on translational research,” he said. “In addition, it has allowed me to learn the special requirements for pharmacy services to conduct early stage clinical trials.”
Prior to the NIH, he held various management and teaching positions with the University of Minnesota Hospital and Clinics, and College of Pharmacy.
“I really learned about pharmacy practice and creating a successful environment for academic pharmacy from tremendous mentors at the University of Minnesota,” he said. In addition to academic teaching and administration, he was a member of the management team for a sophisticated pharmacy operation within a large academic medical center.
Daniels has also served as a pharmacist with Target, a consultant pharmacist with the Hennepin Poison Center, and a staff pharmacist at the NIH Clinical Center.
He holds a Ph.D. in social and administrative pharmacy from the University of Minnesota, where he also received an M.S. degree in the same subject areas. His B.S. in pharmacy is from the University of Arizona, he completed a residency in hospital pharmacy with the NIH, and also completed an American Foundation for Pharmaceutical Education Fellowship.
Daniels is a member of major pharmacy associations and societies, he has published more than three dozen scientific and professional articles or book chapters, and he has received numerous awards, such as recognition as one of the Most Influential Pharmacists of 1999 by American Druggist Magazine, and the Best-Practices in Health-System Pharmacy Management Award for Chemotherapy Errors Prevention Task Force in 2000. His research interests include pharmacoeconomics, health related quality-of-life, and epidemiologic evaluation of medication errors.
# # #
News Media Contact
UCSD Health Sciences Communications HealthBeat: /news/